Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: Differences between Europe and the USA

BMC Infectious Diseases

Volumn 7, Issue , 2007, Pages

  Newell, Marie Louise ^a   Huang, Sharon ^b   Fiore, Simona ^a   Thorne, Claire ^a   Mandelbrot, Laurent ^c   Sullivan, John L ^d   Maupin, Robert ^e   Delke, Isaac ^f   Watts, D Heather ^g   Gelber, Richard D ^b   Cunningham, Coleen K ^h   Dorenbaum, Alejandro ⁱ   Mofenson, Lynne ^g   Culnane, Mary ^j   Bazin, Brigitte ^k   Britto, Paula ^l   Balasubramanian, Rajalakshm ^l   Bryson, Yvonne ^m   Cunningham Schrader, Bethann ⁿ   Kaiser, Kathleen A ⁿ   Estep, Scharla ^j   Gigliotti, Maria ^o   Gonzalez Garcia, Adolfo ^p   Mirochnick, Mark ^q   Rekacewicz, Claire ^k   Delfraissy, Jean Francois ^k   Shannon, Maureen ^r   Pahwa, Savita ^p   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^c HÔPITAL LOUIS MOURIER   (France)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^k ANRS   (France)

^l HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^o Boehringer   (Germany)

^p UNIVERSITY OF MIAMI   (United States)

^q BOSTON UNIVERSITY   (United States)

^r SAN FRANCISCO GENERAL HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NEVIRAPINE; PLACEBO; VIRUS RNA;

ARTICLE; CESAREAN SECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EUROPE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MONOTHERAPY; MULTICENTER STUDY; NEWBORN; PREGNANT WOMAN; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SEXUALLY TRANSMITTED DISEASE; SPONTANEOUS ABORTION; UNITED STATES; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION; ADULT; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG EFFECT; GESTATIONAL AGE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; RISK FACTOR; STATISTICS; UTILIZATION REVIEW; VIROLOGY;

ABORTION, SPONTANEOUS; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CESAREAN SECTION; COHORT STUDIES; DISEASE TRANSMISSION, VERTICAL; EUROPE; FEMALE; GESTATIONAL AGE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; RISK FACTORS; UNITED STATES; VIRAL LOAD;

EID: 34447503530     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-7-60     Document Type: Article

References (44)

1. European Collaborative Study Risk factors for mother-to-child transmission of HIV-1 Lancet 1992 vol. 339 1007-1012 10.1016/ 0140-6736(92)90534-A
2. Blanche S Rouzioux C Moscato ML Veber F Mayaux MJ Jacomet C Tricoire J Deville A Vial M Firtion G A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group N Engl J Med 1989 320 1643-1648 2657430
3. Landesman SH Kalish LA Minkoff HL Fox HE Zorrilla C Garcia PM Fowler MG Mofenson LM Tuomala RE The Women and Infants Transmission Study Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother-to-child N Eng J Med 1996 334 1617-1623 10.1056/ NEJM199606203342501
4. Dabis F Msellati P Dunn DT Lepage P Newell ML Perre P Working Group on Mother-to-Child Transmission of HIV Estimating the rate of mother-to-child transmission of HIV. Report of a workshop on methodological issues, Ghent (Belgium), 17-20 February 1992 AIDS 1993 7 1139-1148 10.1097/00002030-199308000-00027 8104423
5. Nair P Alger L Hines S Seiden S Hebel R Johnson JP Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women J Acquir Immune Defic Syndr 1993 6 298-302 8450405
6. Kind C Brandle B Wyler CA Calame A Rudin C Schaad UB Schupbach J Senn HP Perrin L Matter L The Swiss Neonatal HIV Study Group Epidemiology of vertically transmitted HIV-1 infection in Switzerland: Results of a nationwide prospective study Eur J Pediatr 1992 151 442-448 10.1007/ BF01959360 1628673
7. Abrams EJ Matheson PB Thomas PA Thea DM Krasinski K Lambert G Shaffer N Bamji M Hutson DG Grimm K Kaur A Rogers MF New York City Perinatal HIV Transmission Collaborative Study Group Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth Pediatrics 1995 96 451-458 7651777
8. European Collaborative Study The mother-to-child HIV transmission epidemic in Europe: Evolving in the East and established in the West AIDS 2006 20 1419-1427 16791017
9. Ryder RW Behets F Reasons for the wide variation in reported rates of mother-to-child transmission of HIV-1 AIDS 1994 8 1495-1497 7818823
10. Cohen MH Cook JA Grey D Young M Hanau LH Tien P Levine AM Wilson TE Medically eligible women who do not use HAART: The importance of abuse, drug use, and race Am J Public Health 2004 94 1147-1151 1448413 15226135
11. Hamers FF Batter V Downs AM Alix J Cazein F Brunet JB The HIV epidemic associated with injecting drug use in Europe: Geographic and time trends AIDS 1997 11 1365-1374 10.1097/00002030-199711000-00011 9302447
12. European Collaborative Study Vertical transmission of HIV-1: Maternal immune status and obstetric factors AIDS 1996 10 1675-1681 8970688
13. Hamers FF Downs AM The changing face of the HIV epidemic in western Europe: What are the implications for public health policies? The Lancet 2004 364 83-94 10.1016/S0140-6736(04)16594-X
14. Centers For Disease Control and Prevention HIV/AIDS Surveillance in Women Slide Series www://cdcgov/hiv/graphics/womenhtm 2004 L264
15. Dominguez KL Lindegren ML D'Almada PJ Peters VB Frederick T Rakusan TA Ortiz IR Hsu HW Melville SK Sadek R Fowler MG Increasing Trend of Cesarean Deliveries in HIV-Infected Women in the United States From 1994 to 2000 J Acquir Immune Defic Syndr 2003 33 232-238 10.1097/ 00126334-200306010-00019 12794560
16. Centers For Disease Control and Prevention Enhanced Perinatal Surveillance - United States, 1999-2001 Atlanta, US Department of Health and Human Sciences 4 2004 1-22
17. Gebo KA Fleishman JA Conviser R Reilly ED Korthuis PT Moore RD Hellinger J Keiser P Rubin HR Crane L Hellinger FJ Mathews WC Network HIVR Racial and gender disparities in receipt of highly active antiretroviral therapy persist in multstate sample of HIV patients in 2001 J Acquir Immune Defic Syndr 2005 38 96-103 10.1097/00126334-200501010-00017 15608532
18. Palacio H Kahn JG Richards TA Morin SF Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: A review of the literature Public Health Rep 2002 117 233-251 1497431 12432135
19. European Collaborative Study Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe Br J Obstet Gynaecol 1998 105 704-709 9692409
20. Dorenbaum A Cunningham CK Gelber RD Culnane M Mofenson LM Britto P Rekacewicz C Newell ML Delfraissy JF Cunningham-Schrader B Mirochnick M Sullivan JL Team IPACTG Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission. A randomised trial. JAMA 2002 288 189-198 10.1001/jama.288.2.189 12095383
21. Fiore S Thorne C Newell ML European involvement in an international perinatal trial. Developmental Period Medicine 2003 7 449-458 15010555
22. Connor EM Sperling RS Gelber RD Kiselev P Scott GB O'Sullivan MJ Van Dyke R Bey M Shearer WT Jacobson RL Jimenez E O'Neill E Bazin B Delfraissy JF Culnane M Coombs RW Elkins MM Moye JJ Stratton P Balsey J Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment N Eng J Med 1994 331 1173-1180 10.1056/NEJM199411033311801
23. Hamers FF Infuso A Alix J Downs AM Current situation and regional perspective on HIV/AIDS surveillance in Europe J Acquir Immune Defic Syndr 2003 32 S39-S48 12571514
24. Mosher WD Bachrach CA Understanding U.S. fertility: Continuity and change in the National Survey of Family Growth, 1988-1995 Fam Plann Perspect 1996 28 4-12 10.2307/2135956 8822409
25. The CAESAR Coordinating Committee Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: The CAESAR trial Lancet 1997 349 1413-1421 10.1016/S0140-6736(97)04441-3 9164314
26. Carpenter CCJ Fischl MA Hammer SM Hirsch MS Jacobsen DM Katzenstein DA Montaner JSG Richman DD Saag MS Schooley RT Thompson MA Vella S Volberding PA Antiretroviral therapy for HIV infection in 1997: Updated recommendations of the International AIDS Society-USA panel JAMA 1997 277 1962-1969 10.1001/jama.277.24.1962 9200638
27. Cooper ER Charurat M Mofenson LM Hanson IC Pitt J Diaz C Hayani K Handelsman E Smeriglio V Hoff R Blattner WA Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission J Acquir Immune Defic Syndr 2002 29 484-494 11981365
28. European Collaborative Study HIV-infected pregnant women and vertical transmission in Europe since 1986 AIDS 2001 15 761-770 10.1097/ 00002030-200104130-00012 11371691
29. Mandelbrot L Le Chenadec J Berrebi A Bongain A Benifla JL Delfraissy JF Blanche S Mayaux MJ Cohort FP Perinatal HIV-1 Transmission - Interaction Between Zidovudine Prophylaxis and Mode of Delivery in the French Perinatal Cohort. JAMA 1998 280 55-60 10.1001/jama.280.1.55 9660364
30. European Collaborative Study Pregnancy-related changes in the longer-term management of HIV infected women in Europe Eur J Obstet Gynecol Reprod Biol 2003 111 3-8 10.1016/S0301-2115(03)00153-2 14557003
31. The Italian Register for HIV Infection in Children Determinants of mother-to-infant human immunodeficiency virus 1 transmission before and after the introduction of zidovudine prophylaxis Arch Pediatr Adolesc Med 2002 156 915-921 12197800
32. European Collaborative Study Mother-to-child transmission of HIV Infection in the era of highly active antiretroviral therapy Clin Infect Dis 2005 40 458-465 10.1086/427287 15668871
33. Warszawski J Tubiana R Le Chenadec J Blanche S Teglas JP al Is intrapartum intravenous zidovudine still beneficial to prevent mother-to-child HIV-1 transmission? 12th Conference on Retroviruses and Opportunistic Infections, 22-25 February 2005, Boston, USA 2005 Abstract 781
34. Mandelbrot L Landreau A Rekacewicz C Berrebi A Benifla JL Burgard M Lachassine E Chaix ML Bongain A Ciraru-Vigneron N Crenn-Herbert C Delfraissy JF Rouzioux C Mayaux MJ Blanche S the Agence Nationale de Recherches sur le SIDA ANRSG Lamivudine-Zidovudine Combination for Prevention of Maternal-Infant Transmission of HIV-1 JAMA 2001 285 2083 2093 10.1001/jama.285.16.2083 11311097
35. Cunningham CK Balasubramanian R Delke I Maupin R Mofenson L Dorenbaum A Sullivan JL Gonzalez-Garcia A Thorpe E Rathore M Gelber RD The impact of race/ethnicity on mother-to-child HIV transmission in the United States in Pediatric AIDS Clinical Trials Group Protocol 316 J Acquir Immune Defic Syndr 2004 36 800-807 10.1097/00126334-200407010-00006 15213563
36. Fiscus SA Adimora AA Funk ML Schoenbach VJ Tristram D Lim W McKinney RE Rupar D Woods C Wilfert C Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina Pediatr Infect Dis J 2002 21 664-668 10.1097/00006454-200207000-00012 12237600
37. Stringer JSA Rouse DJ Goldenberg RL Prophylactic cesarean delivery for the prevention of perinatal human immunodeficiency virus transmission. The case for restraint JAMA 1999 281 1946-1949 10.1001/jama.281.20.1946 10349900
38. Brockmeyer N German-Austrian Guidelines for HIV-therapy during pregnancy--status: May/June 1998--common statement of the Deutsche AIDS-Gesellschaft (DAIG) and the Osterreichische AIDS-Gesellschaft (OAG) Eur J Med Res 1999 4 35-42 9892574
39. Taylor GP Lyall EGH Mercey D Smith JR Chester T Newell ML Tudor-Williams G British HIV Association guidelines for prescribing antiretroviral therapy in pregnancy (1998) Sexually Transmitted Infections 1999 75 90-97 10448360
40. Newell ML Rogers MF Pregnancy and HIV infection: A European Consensus on management AIDS 2002 16 S1-S18 12479261
41. British HIV Association Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV London, British HIV Association 2005 www.bhiva.org
42. Hankins C Lapointe N Walmsley S Participation in clinical trials among women living with HIV in Canada. Canadian Women's HIV Study Group CMAJ 1998 159 1359-1365 1229853 9861204
43. Gandhi M Ameli N Bacchetti P Sharp GB French AL Young M Gange SJ Anastos K Holman S Levine A Greenblatt RM Eligibility criteria for HIV clinical trials and generalizability of results: The gap between published reports and study protocols AIDS 2005 19 1885-1896 10.1097/ 01.aids.0000189866.67182.f7 16227797
44. Moore DAJ Goodall RL Ives NJ Hooker M Gazzard BG Easterbrook PJ How generalizable are the results of large randomized controlled trials of antiretroviral therapy? HIV Medicine 2000 1 149-154 10.1046/ j.1468-1293.2000.00019.x 11737343